The effect of sevoflurane postconditioning on cardioprotection against ischemia-reperfusion injury in rabbits

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Biology Reports

• Publication date

  2012-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11033-011-1419-5PMID 22228087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane- but not propofol-treated hearts.

  2011cited by this paper
• Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia–reperfusion

  2010cited by this paper
• Attenuation of ischemia–reperfusion injury by sevoflurane postconditioning involves protein kinase B and glycogen synthase kinase 3 beta activation in isolated rat hearts

  2010cited by this paper
• Cytoprotective effects of the volatile anesthetic sevoflurane are highly dependent on timing and duration of sevoflurane conditioning: findings from a human, in-vitro hypoxia model.

  2010cited by this paper
• Comparison of Isoflurane-, Sevoflurane-, and Desflurane-Induced Pre- and Postconditioning Against Myocardial Infarction in Mice In Vivo

  2009cited by this paper
• A comparison of volatile and non volatile agents for cardioprotection during on‐pump coronary surgery

  2009cited by this paper
• Reactive Oxygen Species–Induced Stimulation of 5′AMP-Activated Protein Kinase Mediates Sevoflurane-Induced Cardioprotection

  2009cited by this paper
• Is postconditioning effective in prevention against long-lasting myocardial ischemia in the rabbit?

  2009cited by this paper
• Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion.

  2009cited by this paper
• Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial.

  2007cited by this paper
• Anesthetic Preconditioning Combined with Postconditioning Offers No Additional Benefit Over Preconditioning or Postconditioning Alone

  2007cited by this paper
• Effects of sevoflurane and propofol on ischaemia-reperfusion injury after thoracic-aortic occlusion in pigs.

  2007cited by this paper
• Isoflurane and sevoflurane during reperfusion prevent recovery from ischaemia in mitochondrial KATP channel blocker pretreated hearts

  2006cited by this paper
• Postconditioning Inhibits Mitochondrial Permeability Transition

  2005cited by this paper
• Isoflurane and sevoflurane during reperfusion prevent recovery from ischemia in mitochondrial K[ATP] channel blocker pretreated hearts

  2005cited by this paper
• Anesthetic myocardial protection with sevoflurane.

  2004cited by this paper
• Evidence for a Ceiling of Cardioprotection with a Nitric Oxide Donor-Induced Delayed Preconditioning in Rabbits

  2003cited by this paper
• Anesthetic Preconditioning: Effects on Latency to Ischemic Injury in Isolated Hearts

  2003cited by this paper
• Anaesthetics and cardiac preconditioning. Part II. Clinical implications.

  2003cited by this paper
• One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo.

  2001cited by this paper
• Kardiovaskuläre Effekte von Sevofluran

  1998cited by this paper
• [Cardiovascular effects of sevoflurane].

  1998cited by this paper
• [The cardiovascular effects of sevoflurane].

  1996cited by this paper
• Progression of myocardial infarction in a collateral flow deficient species.

  1989cited by this paper

• Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies

  2025cites this paper
• The Protective Effect of Sevoflurane Conditionings Against Myocardial Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Trials in in-vivo Models

  2022cites this paper
• Cardioprotection of pharmacological postconditioning on myocardial ischemia/reperfusion injury.

  2020cites this paper
• Pharmacology of mitochondrial permeability transition pore inhibitors

  2019cites this paper
• The Dual Neuroprotective-Neurotoxic Effects of Sevoflurane After Hemorrhagic Shock Injury.

  2019cites this paper
• Downregulation of Na+/Ca2+ Exchanger Isoform 1 Protects Isolated Hearts by Sevoflurane Postconditioning but Not by Delayed Remote Ischemic Preconditioning in Rats

  2017cites this paper
• Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.

  2017cites this paper
• Age-associated differences in response to sevoflurane postconditioning in rats

  2016cites this paper
• The mechanisms of cardio-protective effects of desflurane and sevoflurane at the time of reperfusion: anaesthetic post-conditioning potentially translatable to humans?

  2016cites this paper
• Effect of combination therapy of propofol and sevoflurane on MAP2K3 level and myocardial apoptosis induced by ischemia-reperfusion in rats.

  2015cites this paper
• Effect of combination therapy of propofol and sevoflurane on MAP 2 K 3 level and myocardial apoptosis induced by ischemia-reperfusion in rats

  2015cites this paper
• Delayed Remote Ischemic Preconditioning Produces an Additive Cardioprotection to Sevoflurane Postconditioning Through an Enhanced Heme Oxygenase 1 Level Partly Via Nuclear Factor Erythroid 2-Related Factor 2 Nuclear Translocation

  2014cites this paper
• Post-conditioning at the ischemic region of the heart to prevent acute kidney injury in patients with non-ST-segment elevation myocardial infarction.

  2013cites this paper
• Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway.

  2012cites this paper